Panmure Gordon reissued their buy rating on shares of Dechra Pharmaceuticals (LON:DPH) in a research report released on Monday morning, StockRatingsNetwork.com reports. Panmure Gordon currently has a GBX 850 ($13.94) price objective on the stock. A number of other firms have also recently commented on DPH. Analysts at Investec cut their price target on shares […]
Dechra Pharmaceuticals Rating Reiterated by Panmure Gordon (DPH) is a post from: Zolmax
The post Dechra Pharmaceuticals Rating Reiterated by Panmure Gordon (DPH) appeared first on Zolmax.